Skip to main content

METHODS article

Front. Vet. Sci., 08 March 2019
Sec. Veterinary Infectious Diseases

Optimization of a Loop Mediated Isothermal Amplification (LAMP) Assay for In-Field Detection of Dichelobacter nodosus With aprV2 (VDN LAMP) in Victorian Sheep Flocks

\r\nNickala BestNickala Best1Grant RawlinGrant Rawlin2Robert SuterRobert Suter3Brendan RodoniBrendan Rodoni2Travis Beddoe*Travis Beddoe1*
  • 1Beddoe Laboratory, Department of Animal, Plant and Soil Science, La Trobe University, Melbourne, VIC, Australia
  • 2Centre for AgriBioscience (AgriBio), Department of Economic Development, Jobs, Transport and Resources, Victorian Government, Melbourne, VIC, Australia
  • 3Agriculture Services and Biosecurity Operations, Department of Economic Development, Jobs, Transport and Resources, Victorian Government, Attwood, VIC, Australia

Dichelobacter nodosus is the primary etiological agent of footrot in sheep and has a variety of virulence factors. Of these, AprV2, an extracellular protease, has been shown to be capable of causing severe or “virulent” disease symptoms under the right conditions. Due to this, a loop-mediated isothermal amplification (LAMP) assay for the detection of aprV2-positive D. nodosus (VDN LAMP) was developed and evaluated for field use. A sample of 19 sheep flocks (309 sheep) in Victoria, Australia, were tested to determine the optimum conditions for in-field VDN LAMP assay use and sampling, for detecting aprV2-positive D. nodosus infected sheep. VDN LAMP performance was compared to a validated rtPCR that detects aprV2 and the benign strain counterpart, aprB2, using biologically duplicate samples to determine sensitivity and specificity. Flocks were sampled either in winter-spring (moist) or early summer (dry) conditions and had a range of clinical expressions of the disease ovine footrot. Variables considered for optimizing field performance were: sample collection method, sample preparation, clinical expression of disease, and nature of the feet when sampled (moist vs. dry, clean vs. soiled). The test was found to perform best when sheep were sampled with moist, clean feet, using a dry swab with the sample prepared in alkaline polyethylene glycol, pH 13.0, as the collection buffer. A sensitivity of 89% and specificity of 97% was seen when used in-field under these conditions, when compared to aprV2 detection by rtPCR, with “very good” agreement to rtPCR results. This study shows the VDN LAMP test is easy to use in-field to identify the presence of aprV2-positive D. nodosus in sheep flocks.

Introduction

Footrot in sheep is a disease that causes considerable welfare and economic concerns. Dichelobacter nodosus, a gram-negative bacterium, is the primary etiological agent and causes the hard hoof to separate or “underrun” from the soft underlying tissue of the sheep foot (1). In Australia, clinical footrot is divided into two forms—benign and virulent. This is referring to the visual symptoms of D. nodosus infection and in Victoria is based on a modified Egerton scoring system of 1–5 (2). In Victoria, a flock is considered to have clinically virulent footrot when 1% or more of the inspected flock have score 4 or 5 lesions, while scores of 1 and 2 are indicative of benign footrot and show symptoms resembling interdigital dermatitis (3). Footrot is easily spread over the pasture, particularly in Spring in Victoria (September–November), posing a biosecurity threat both on the farm between flocks and in the larger industry (4, 5).

The clinical severity of the disease is an interplay between sheep genetics (resistance), bacterial genetics (strain virulence), and environmental conditions (6). Two extracellular protease genes, aprV2, and aprB2 have been shown to correlate to the clinical severity of disease (7, 8). Of these, aprV2 is found in D. nodosus strains capable of causing virulent footrot, while aprB2 is associated with benign footrot (7, 9). The genetic basis for the difference in disease severity is a 2-base pair change, which results in a single amino acid difference from tyrosine in the secreted AprV2 protease, to arginine in AprB2, located at the tip of the “I2” loop (10, 11). This conveys a difference in thermostability of the proteases, with AprV2 showing increased stability in heat (11).

Real-time polymerase chain reaction (rtPCR) methods have been developed for the detection of D. nodosus, and the identification of aprV2/aprB2, with results from foot swabs obtained within a day (12, 13). These molecular methods can detect co-infection and quantitate bacterial loads. In comparison, culturing methods are more labor intensive and require specialist media, taking several weeks for a result (3). Current research shows foot scores 1 and 2 present with the highest bacterial load of D. nodosus (12, 14, 15). This suggests early detection of D. nodosus, in particular, those strains possessing aprV2, could have management implications, with molecular methods helping to make informed and timely disease management decisions. Detection of infection early, prior to severe disease symptoms, may help with preventing progression to virulent footrot. Although an rtPCR can provide a quick confirmation of diagnosis, these assays are still not capable of being used in-field for real-time clinical decision making.

An in-field assay for aprV2-positive D. nodosus has been developed using loop-mediated isothermal amplification (LAMP) (16). LAMP has consistently been shown to be tolerant to biological substances that commonly inhibit conventional or rtPCR assays, such as serum, plasma, urine, aqueous humics, feces, and vitreous (17). In addition to this, LAMP is robust and can tolerate extended periods of warming, 2 pH unit changes, and 10°C changes in operating temperatures (18). With these properties, LAMP is consistently identified as suitable for field use, however, few developed methods have been reported to progress to in-field use (19, 20).

A LAMP for the detection of aprV2-positive D. nodosus (VDN LAMP) has been developed and a pilot study for in-field use reported previously (16). Using this method, a field trial on 19 sheep properties across Victoria, Australia, has been conducted. Here we report the results of the field trial, comparing VDN LAMP to aprV2/aprB2 rtPCR, using 309 sheep. We report recommendations for optimized performance when sampling and use in-field.

Materials and Methods

Control Strains

Genomic DNA (gDNA) was extracted from cultured cells of D. nodosus isolate A198 (aprV2 positive) (AC: 6466) using PrepMan® Ultra Sample Preparation (Life Technologies) as per manufacturer's instructions. The D. nodosus isolate gDNA extraction was used as a positive control throughout and was provided by DAFWA Diagnostics and Laboratory Services (Department of Agriculture and Food Western Australia).

Field Sample Preparation

A series of field sampling methods were screened in the laboratory before field use (Supplementary Data 1). The final method chosen for sample collection and processing was a dry swab (CLASSIQSwabs, Copan Italia), taken from the interdigital space, or if a lesion was present, the lesion edge and collected into 500 μL alkaline polyethylene glycol (PEG) at pH 13.0.

A sampling matrix was re-created to determine an appropriate dilution for use, using purpose collected sheep samples, confirmed by aprV2/aprB2 rtPCR (12) as D. nodosus negative. Buffer from 5 samples was pooled and aliquoted in 500 μL volumes to distribute inhibitors evenly, before artificial spiking with A198 D. nodosus broth (3). A 10 times cell dilution series of 2.05 × 108 cells/mL was made, before spiking 50 μL into the buffer. A secondary dilution series of buffer was made, and 5 μL used directly as rtPCR template for the screening of an appropriate dilution for field use. Cell numbers were calculated using OD600 calculations of neat broth. All cell/buffer dilution combinations were tested using the aprV2/aprB2 rtPCR (12). Dry swabs collected into 500 μL alkaline PEG, pH 13.0 and a 1:100 dilution of the crude extract was subsequently used as VDN LAMP template throughout the study.

Sample Collection

This study was carried out in accordance with the recommendations of the La Trobe University animal ethics committee. The protocol was approved by the La Trobe University animal ethics committee with approval number AEC17-21. VDN LAMP field swabs were collected from August to December 2017. Properties were convenience sampled. Current clinical foot scores (Table 1) of the sheep feet were recorded and the single highest scored foot was sampled. Two swabs per sampled sheep were collected simultaneously as above and used as biological duplicates. Per property, 14 sheep were sampled. One swab was used for aprV2/aprB2 rtPCR and the second for immediate in-field processing with VDN LAMP.

TABLE 1
www.frontiersin.org

Table 1. Modified Egerton foot scoring used to class clinical signs of footrot.

Swabs for aprV2/aprB2 rtPCR were collected into 600 μL phosphate buffered saline (PBS) with 20 mM ethylenediaminetetraacetic acid (EDTA), pH 8.0. Swab heads were snapped into the buffer tubes and were not removed, with transport at 4°C before processing in the laboratory.

Swabs for in-field processing with VDN LAMP were placed into 500 μL alkaline polyethylene glycol, pH 13.0. Swab heads were snapped into the buffer tubes and left in, with collection and processing occurring at ambient temperature.

In-Field D. nodosus Strain Typing Using VDN LAMP

VDN LAMP swabs were left in collection buffer for a minimum of 10 min at ambient temperature, ranging from ~6 to 35°C, before template preparation. The template was prepared by diluting the alkaline PEG containing the swab, pH 13.0, 1:100, using a disposable 10 μL inoculation loop and placing the loop of liquid into 990 μL H2O in a microfuge tube. Microfuge tubes were then shaken and 5 μL of this dilution was added via pipette directly to VDN LAMP reaction mixture as a template.

VDN LAMP reactions were carried out as follows; 25 μL total volume using 15 μL OptiGene GspSSD2.0 Isothermal Mastermix (ISO-DR004), 5 μL primer mix (final concentrations of 1.6 μM FIP and BIP, 0.2 μM F3, B3, and LF) (Bioneer), and 5 μL template. Primers used are as previously described (Table 2) (16). Aliquots of all reagents were prepared prior to the property visit in volumes required for one property and were transported in microfuge tubes in a cooler box with ice blocks. Mixing of reagents in-field was performed with a pipette. Transport times ranged from 4 to 10 h.

TABLE 2
www.frontiersin.org

Table 2. Primer sequence and corresponding LAMP primer design region on sequence.

VDN LAMP was run on the Genie II (Optigene, UK) real-time fluorometer, with the following conditions; 40°C preheat for 60 s, 65°C for 20 min, annealing from 94 to 84°C at a rate of 0.5°C/s. Results are reported as the time to positive (Tp) (minutes.seconds) and anneal melting temperature (Tm) (°C), given when the sample fluorescence crossed the pre-set machine threshold of 0.010 fluorescence units.

A run was considered valid if the A198 (aprV2-positive) control strain gDNA amplified before 13 min and gave a Tm within the range of 87.7 and 88.7°C, and the no template control (MilliQ H2O) showed no amplification. A sample was considered positive if the following criteria were met; a result of both a Tp of ≤20 min and a Tm within 87.7 and 88.7°C.

Nucleic Acid Extraction and rtPCR for D. nodosus Strain Typing

Using 50 μL of the 600 μL buffer, samples for rtPCR had all nucleic acids present extracted and purified using the MagMax Viral RNA extraction kit (Thermo Fisher Scientific) and Kingfisher-96 magnetic particle handling system (Thermo Fisher Scientific) as per manufacturer's instructions. The presence of aprV2 and/or aprB2 in samples were identified using primers, probes and cycling conditions as described by Stäuble et al. (12). The AgPath-IDTM One-Step RT-PCR Kit (Ambion, Austin, USA) was used as master mix according to manufacturer's instructions, adapted for 10 μL final volume. Primers and probes were synthesized and supplied by Applied Biosystems (California, USA). Reactions and analysis were carried out on the Mic qPCR Cycler (BioMolecular Systems, Queensland, Australia), using auto threshold detection and bulk analysis.

Statistics

Statistics were performed using Microsoft Excel 2016 and GraphPad Prism 6. The following criteria were applied to all results;

• rtPCR positive samples have Ct values of under 35 (21)

• rtPCR arpV2 positive samples have aprV2 present, either singularly or in a mixed infection with aprB2

• rtPCR aprV2 negative samples have arpB2 only present, or are D. nodosus negative

• VDN LAMP positive samples showed both a Tp before 20 min and a Tm between 87.70 and 88.70°C at the time of processing in-field

The level of agreement between rtPCR and VDN LAMP was evaluated using Cohen's kappa coefficient from Fleiss and Levin (22) and interpreted using the strength of agreements of the Altman scheme where ≤0 = worse than chance alone, <0.20 = poor, 0.21–0.40 = fair, 0.41–0.60 = moderate, 0.61–0.80 = good, and 0.81–0.99 = very good, 1.00 = perfect. The Pearson correlation coefficient was used to measure the linear correlation between Tp and the Ct value of paired samples.

To compare in field VDN LAMP to lab-based rtPCR, VDN LAMP sensitivity (Se) is defined as the percentage of VDN LAMP positive samples within rtPCR aprV2 positive samples, while VDN LAMP specificity (Sp) is defined as the percentage of VDN LAMP negative samples within rtPCR aprV2 negative samples. Se, Sp, were calculated using GraphPad Prism 6, along with the negative predictive value (NPV) and positive predictive value (PPV).

Property details including breed, age, and sex of sampled sheep were recorded, in addition to the physical properties of samples, the date and ambient temperature of the day of sampling.

VDN LAMP results were also analyzed against rtPCR results for sensitivity and specificity with the following parameters;

• Sample moisture (SM) for each property. SM was designated as follows; moist (M), where moisture was present in the interdigital skin, either through the environment or being “sweaty,” as seen when clinical symptoms are present, and dry (D), where the interdigital skin had no moisture present, either from the environment or clinical symptoms.

• Presence of dirt when sampling for each property; clean samples had minimal dirt and feces present (C), while soiled samples (S) had enough dirt and feces to collect onto the swab and significantly color the buffer (Figure 1).

• Property clinical status. Sheep properties were designated as follows; virulent (V), where there are clinical foot scores 4+ present on the property; benign (B), where there are scores of 1 and 2, with this including two sheep properties where 1/14 sheep sampled were scored 3; and negative (N), where all foot scores are 0.

• Ct value ranges of paired swabs, with results grouped as Ct <25, 25 ≤ 30, and 30 ≤ 35.

FIGURE 1
www.frontiersin.org

Figure 1. Examples of what was considered a “clean” and “soiled” sample. Care was taken to try and minimize the amount of particulate collected on the swab before placement into buffer.

Results

Field Sample Preparation

From the nine methods investigated for field processing of samples, a swab collected into 500 μL alkaline PEG, pH 13.0, was the easiest sampling method to perform with the least amount of equipment. FTA cards produced minimal positive results, while the other swab methods worked well yet proved to be inconvenient or did not show a positive result (Supplementary Data 1). Using 1:100 diluted alkaline PEG, pH 13, directly as the template, a sensitivity of ~1,000 D. nodosus cells was able to be detected at a Ct of 35 (Table 3), as determined by rtPCR. A 1:100 dilution of the swab extract provided positive Ct values across a range of cell dilutions and is recommended by the authors of the method to reduce the pH to a more favorable level for DNA amplification (23), while also diluting inhibitors.

TABLE 3
www.frontiersin.org

Table 3. Ct values when using the aprV2/aprB2 rtPCR and various aprV2 positive D. nodosus cell concentrations diluted into alkaline PEG buffer (pH 13), and subsequent buffer dilutions into H2O.

All Data—D. nodosus Strain Typing In-Field, Sensitivity, Specificity, Positive, and Negative Predictive Value

The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the in-field VDN LAMP was calculated by direct comparison with the aprV2 rtPCR Ct values as determined from the biologically duplicate swabs.

The in-field processing with VDN LAMP gives a sensitivity of 59.62% (Table 4), detecting 93 of the 156 samples that were aprV2 rtPCR positive. A specificity of 97.39% is seen for all data, with 4/153 samples that were aprV2 negative testing positive using the VDN LAMP. There is “moderate” agreement between the two methods when comparing aprV2 positives using Cohen's Kappa coefficient.

TABLE 4
www.frontiersin.org

Table 4. Sensitivity, specificity, and corresponding positive and negative predictive values when comparing identification of aprV2 presence between the aprV2/aprB2 rtPCR and VDN LAMP assays on biologically duplicate samples.

Optimizing Sampling Conditions In-Field for VDN LAMP Performance

Some of the likely variables to be encountered during in-field sampling were investigated for effects on assay performance. Sample quality (presence/absence of moisture and dirt), current designation of clinical footrot on the property, and various combinations of these variables were chosen to assist in optimizing sampling procedures in the context of footrot and season of sampling.

Sample Quality (Moisture and Presence of Dirt)

The first sampling factor investigated was the presence (moist, M) or absence (dry, D) of moisture in the interdigital space or lesion when collecting the sample. When sampling with moisture present, the sensitivity of VDN LAMP when compared to the aprV2/aprB2 rtPCR is 83.82%, compared to 39.13% when no moisture is present (Table 5).

TABLE 5
www.frontiersin.org

Table 5. The sensitivity and specificity of the VDN LAMP when compared to the arpV2/aprB2 rtPCR of moist (M) or dry (D) samples collected from 309 individual sheep.

The sensitivity of VDN LAMP was reduced in the presence of excessive contaminants in the sample (Table 6). Clean (C) samples have minimal dirt and feces present, while soiled (S) samples had significant contaminants being collected onto the swab. Samples that were both moist and clean (MC) gave an increased sensitivity of 88.89% for the VDN LAMP when compared to the aprV2/aprB2 rtPCR. Moist and soiled (MS) samples had a sensitivity of 73.91%, while dry and clean (DC) samples a sensitivity of only 39.58% and dry and soiled samples (DS) had a sensitivity of 38.63%.

TABLE 6
www.frontiersin.org

Table 6. The sensitivity and specificity of the VDN LAMP when compared to the arpV2/aprB2 rtPCR of moist and clean (MC), moist and soiled (MS), dry and clean (DC), or dry and soiled (DS) samples collected from 309 individual sheep.

Clinical Status of Sheep Properties

VDN LAMP sensitivity increases as the clinical severity of footrot increases, when based on property designation. Those sheep properties considered “negative” (N) for footrot had a sensitivity of 44.44% when compared to the aprV2/aprB2 rtPCR, while a small difference in sensitivity was observed between a “virulent” (V) designation and a “benign” (B) designation (65.15 and 56.79%, respectively). The “virulent” sheep properties had a lower specificity (88.24%), when compared to the “benign” sheep properties (99.03%) (Table 7).

TABLE 7
www.frontiersin.org

Table 7. The clinical property designation (V, virulent, B, benign, N, negative), number of animals within the property designation and the calculated sensitivity and specificity of VND LAMP in comparison to aprV2/aprB2 rtPCR.

When both the clinical designation of the property and the moisture status are considered (Table 8), only a slight increase in sensitivity is seen between the benign and virulent groups when sampling “moist” samples (88.24, 83.34%), and similarly poor sensitivity is seen in the “dry” sample groups (42.11, 33.33%). Specificity for the VDN LAMP is highest in the benign group, with both moist and dry sampling, showing 100 and 98.55% specificity, respectively.

TABLE 8
www.frontiersin.org

Table 8. The calculated sensitivity and specificity of VND LAMP in comparison to aprV2/aprB2 rtPCR when combining clinical property designation (V, virulent, B, benign, N, negative), and the sample moisture, where moisture is present (M), or absent (D).

Specificity of In-Field VDN LAMP and Ct Range Variations in Sensitivity

The four VDN LAMP false positives (Table 9) were from sheep with a clinical score of 0. There was no apparent sample quality association with the 4 samples.

TABLE 9
www.frontiersin.org

Table 9. VND LAMP false positive sample summary data, with no rtPCR cut offs applied, and VDN LAMP time to positive (Tp) and anneal temperature (Tm) displayed.

All VDN LAMP results from Table 9 fall within the recommended range for rtPCR confirmation (16). Sample 1 is the only instance of an aprV2 positive rtPCR Ct above 35 being identified by the VDN LAMP. This sample is still considered a false positive due to the Ct 35 cut off that is applied to the aprV2/aprB2 rtPCR. Sample 2 comes from a flock where 10/14 sheep sampled were rtPCR aprV2 positive, while sample 3 came from a flock where 3/14 sheep sampled were co-infected with aprV2 and aprB2 positive strains. An additional 10 sheep from the same property were aprB2 positive. Sample 4 was from a property where all sheep were scored 0, and 1/14 samples were rtPCR aprV2 positive. All samples that were aprV2 rtPCR negative were all from “soiled” samples.

An increase in sensitivity of the VDN LAMP is seen with a decrease in Ct value of the aprV2/aprB2 rtPCR (Table 10), when comparing the Ct value of the aprV2 rtPCR positives with the VDN LAMP from the biologically duplicate swab. The sensitivity of samples with Ct's under 25 increases to 86.0%.

TABLE 10
www.frontiersin.org

Table 10. The number of samples identified as virulent by VDN LAMP from biologically duplicate swabs that were positive for aprV2 via rtPCR, within different Ct ranges (excluding VDN LAMP false positives).

There is a low correlation between Ct value and VDN LAMP Tp, where the Pearson correlation co-efficient is r = 0.3161 (p = 0.002).

Discussion

LAMP technology is still in the early stages of full field deployment, with this study contributing to the understanding of factors that impact performance and the machinations of use in-field. The VDN LAMP reagents and machinery performed as anticipated despite difficulties encountered with in-field use in Australian conditions, such as variation in ambient temperature, ranging from 6 to 35°C, and rain. All in-field runs using the arpV2 gDNA control amplified in 13 min or under, with a Tm in the acceptable range, and the no template control failing to amplify. An adjustment of the previously acceptable Tm range of 88.0–88.9°C to 87.7–88.7°C (16), was deemed necessary after the collection of more field data provided evidence of this range. The chosen in-field sampling method was easy to perform, did not require any machinery and provided consistent results. Though there are few in-field LAMP methods to directly compare to VDN LAMP performance, a study using an in-field laboratory and a real-time LAMP assay for malaria detection reported the sensitivity of 94.1% and specificity of 83.9%. This was using a sample preparation method that included the use of heat treatment, a vortex, centrifuge and aspiration (24), which is significantly more resource intensive than the chosen method presented here. Another study reported a quantitative LAMP for the detection of Erysiphe necator (powdery mildew), in-field and performed by producers (25). This study identified a loss of sensitivity over time when used by growers, with samples (n = 73) collected using custom impaction spore samplers, and prepared with Chelex 100, boiling, and a vortex. The authors were not able to identify the source of sensitivity loss, with technical aspects of the assay investigated.

When the arpV2/aprB2 rtPCR and VDN LAMP positive cut-off parameters as defined in the methods are applied, the overall sensitivity of in-field VDN LAMP is 59.62%, correctly identifying 93/156 aprV2 positive samples, with a specificity of 97.39% (149/153) and a “moderate” agreement to the rtPCR results. The PPV of 95.88% indicates that the presence of a positive sample is reliable, while due to the sensitivity, NPV of 70.28% indicate that a negative result is less reliable. Several factors appeared to influence the sensitivity of in-field testing, with both physical differences in sample and performance between sheep properties noted early on. Of the many factors that can influence a field test, the following variables were investigated for impact on performance; sample moisture, sample cleanliness and the clinical footrot designation of the property. These were chosen as they are important factors when considering technical aspects of LAMP and the context of footrot.

A difference in performance was seen when moisture on the swab is present/absent. Those samples that were “moist” and “clean” showed the highest sensitivity (88.89%) and second highest specificity (97.56%). In contrast, samples that were “dry” and “soiled” had both the lowest sensitivity and specificity (38.63, 92.31%). It should also be noted that those samples that were “dry” and “clean” had similar sensitivity and specificity (39.58, 100%) to “dry” and “soiled.” In addition agreement between the in-field VDN LAMP and the lab based rtPCR was “very good” for moist samples, before lowering to “fair” for “dry” and “soiled” samples. These results suggest that the presence/absence of moisture when sampling is more critical to the success of the assay than the presence/absence of detritus.

It was noted during sampling that interdigital skin or lesions where moisture was present collected visibly more exudate than those where moisture was not present, both making it easier mechanically to perform sampling, but also often indicative of the start of clinical footrot disease symptoms. Recent research has shown that the highest D. nodosus load is found with scores 1 and 2, associated with interdigital dermatitis or benign footrot, which are clinically identical (14, 26, 27). The implication for VDN LAMP being that the early stages of infection are likely to produce the best results, through the increased number of bacteria present (increasing sensitivity as more DNA template is present) and the early clinical symptoms producing a moist exudate that contributes to the presence of moisture in the interdigital skin for ease of sampling. The environmental conditions that provide moisture are also those that are more favorable for the growth of D. nodosus, which requires the presence of moisture to cause disease (28). In addition, moisture presence/absence is influenced by the weather, suggesting the time of year when sampling will have an impact on the performance of the assay, with sampling over dry months not recommended.

On sheep properties designated virulent, the VDN LAMP had a sensitivity of 65.15% with this reduced to 56.79% for benign sheep properties, and further still to 44.44% on negative sheep properties. When considering disease status of the property, VDN LAMP agreement ranged from “fair” to “moderate,” as assessed by the Altmann scale interpreting Cohen's Kappa coefficient. If the presence/absence of moisture is again considered alongside clinical designation, increases to sensitivity are seen for both benign (88%) and virulent (83.34%) sheep properties. This supports the importance of the presence of moisture when sampling, and the benefit of sampling with VDN LAMP in the earlier stages of disease. The improved performance for, at that current time of sampling, “benign” sheep properties, could be beneficial if VDN LAMP is to be used as a tool for the identification of risk for developing severe footrot via detecting aprV2 positive D. nodosus. This type of risk identification approach may be beneficial for sheep producers and veterinarians who wish to prevent any further disease development, based on VDN LAMP results, climatic conditions and individual flock characteristics. It has been suggested that using D. nodosus characteristics rather than clinical expression could improve control outcomes (29), with VDN LAMP and aprV2 detection a potential tool for this type of approach. The elimination of aprV2 positive D. nodosus has been previously demonstrated as possible in Swiss sheep flocks (30).

Of the 309 samples tested, 4/153 samples were in-field VND LAMP positive and rtPCR aprV2 negative. These samples have come from four different sheep properties, with individual sample details listed in Table 9. Of these, sample 1 was aprV2 rtPCR positive, with a Ct value of 37, which is above the Ct cut off for positive samples. This sample came from a currently virulent footrot property and is the only example to date of VDN LAMP detecting a sample with a Ct above 35. Of the other samples, 1/4 was positive for aprB2 (sample 3), and comes from a property designated benign. This property had 3/14 samples aprV2 and aprB2 positive by rtPCR (co-infection), with 13 samples positive for aprB2. The remaining 2/4 VDN false positive samples had no D. nodosus detected by rtPCR and come from a clinically negative (sample 4) and a clinically virulent sheep property (sample 2). The sheep property designated virulent had 10/14 samples rtPCR aprV2 positive, with 3/10 correctly identified by VDN LAMP. The sheep sampled in this instance had typically overgrown hooves, with large amounts of dirt present in the overgrowth, which increased sampling difficulty. It has also been reported previously that in severe lesions that are deep under the horn, D. nodosus is more difficult to access as it resides deep in the lesion. It is possible there was not enough bacteria, and too much soil, for adequate performance of the VDN LAMP, whereas being more stringent and sensitive, the rtPCR was able to identify the aprV2 positive samples. There was 1 sample from a negative property that was rtPCR aprV2 positive and VDN LAMP negative, and a false positive detected within another sample. There is the potential that the 4/153 samples were cross contaminated, but as all samples had Tp's above 18 min, they are within the recommended range for additional testing to confirm results (16). It is also possible that variation between the two biological duplicate swabs exists and has contributed to the variation seen, however there is no way to investigate this retrospectively. Swabs were collected simultaneously with all efforts made to minimize the variation.

As reported previously (16), VDN LAMP's sensitivity in the laboratory increases with a decrease in Ct values of the aprV2/aprB2 rtPCR, and this is true also in-field with paired samples. There is however only a low correlation between the Ct value and Tp, indicating that quantitative analysis from VDN LAMP would not be accurate. The ability to quantitate from LAMP is a source of discussion in the literature (31), and with the results presented here, the authors believe when used in-field the presence/absence of the target is an appropriate interpretation of results. To contrast detection limits for D. nodosus between common methods, it was recently reported that culturing has a detection limit of ~1,000 D. nodosus cells, whereas rtPCR is around 10 cells (32). VDN LAMP falls between this range, detecting approximately 950 D. nodosus cells when estimated using a Ct 30 from biologically duplicate swabs, or 40 cells when considering the lower concentration end of detection, at Ct 35.

That there is no correlation between Tp and bacterial load, plus the variation in VDN LAMP sensitivity seen between sheep properties, the authors suggest the interpretation of results should take into account the proportion of positives in the group and the time of sampling—a single positive on a property with moisture present warrants further investigation using more sensitive methods, or a larger sample size, with VDN LAMP providing a basic screening of the flock. However, if a large portion of the samples are VDN LAMP positive, regardless of Tp, aprV2 does appear to be present in the flock. The 3/4 samples that did not show an rtPCR aprV2 signal, yet were VDN LAMP positive, all came from flocks where there was evidence of arpV2 and varying clinical symptoms of footrot. A flock level interpretation of results is appropriate for typical management practice in Victoria, where traditionally whole flocks are footbathed as a group for treatment.

Conclusion

The VDN LAMP is a new addition to the suite of diagnostics for footrot and is capable of use in-field. This assay offers the fastest time to results, within 1.5 h, which is significantly faster than the well-established culturing methods, and the newer molecular tests. The time taken for an rtPCR result, once samples are transported via cool chain to a laboratory, is 1 day, while culturing routinely takes up to 4 weeks for a virulence result. The VDN LAMP performs best when sampling occurs with moisture present and minimal dirt, with the presence of moisture corresponding to the environment that is ideal for D. nodosus proliferation and expression of virulence factors in Victoria. Sampling at the end of winter/start of spring, which is the traditional time for footrot spread in Victoria, is recommended for increased sensitivity. If used as recommended, the sensitivity of the VDN LAMP is 89% and specificity 97%. Test results in the above context should consider the number of VDN LAMP positives identified and the clinical signs of footrot on the property. Rapid identification of aprV2 positive D. nodosus infection in-field may help reduce spread of footrot through earlier detection, encourage more preventative or new management strategies, and provide evidence or confirmation of infection. Advantages of VDN LAMP in-field for aprV2 positive D. nodosus detection in flocks includes having information of infection in real time, and therefore informing decisions about stock movements and treatment.

Author Contributions

NB performed the experiments and wrote the manuscript. GR, RS, BR, and TB contributed reagents, materials, and/or analytical tools and wrote the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The authors would like to thank the producers who participated in the study for their time and sheep, in addition to the veterinarians that helped put the authors in contact with them. We would also like to thank Dr. Nicky Buller and Eckard Klien for continued D. nodosus culturing support, members of the Rodoni Laboratory for providing various reagents for field sampling method testing, and the initial volunteers for footrot free sheep sampling.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fvets.2019.00067/full#supplementary-material

References

1. Egerton JR, Roberts DS, Parsonson IM. The aetiology and pathogenesis of ovine foot-rot: I. A histological study of the bacterial invasion. J Compar Pathol. (1969) 79:207–17. doi: 10.1016/0021-9975(69)90007-3

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Claxton PD, Stewart DJ. Ovine footrot clinical diagnosis and bacteriology. In: Australian Standard Diagnostic Techniques for Animal Disease. Australian Bureau of Animal Health (1982).

Google Scholar

3. Buller NB, Eamens G. Ovine Footrot - Australian and New Zealand Standard Diagnositic Procedure. S.C.O.a.H.L. Standards (2014).

4. Hinton DG. Eradication of actively spreading ovine footrot. Austr Vet J. (1991) 68:118–9. doi: 10.1111/j.1751-0813.1991.tb00774.x

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Department of Environment and Primary Industries. Footrot in Sheep: 1. Disease Facts [Online]. Department of Environment and Primary Industries (2003). Available online at: http://agriculture.vic.gov.au/agriculture/pests-diseases-and-weeds/animal-diseases/sheep/footrot-in-sheep/footrot-in-sheep-1.-disease-facts (Accessed March, 2009).

6. Skerman TM, Moorhouse SR. Broomfield Corriedales: a strain of sheep selectively bred for resistance to footrot. N Z Vet J. (1987) 35:101–6. doi: 10.1080/00480169.1987.35399

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Kennan RM, Gilhuus M, Frosth S, Seemann T, Dhungyel OP, Whittington RJ, et al. Genomic evidence for a globally distributed, bimodal population in the ovine footrot pathogen Dichelobacter nodosus. MBio. (2014) 5:e01821–14. doi: 10.1128/mBio.01821-14

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Stäuble A, Steiner A, Normand L, Kuhnert P, Frey J. Molecular genetic analysis of Dichelobacter nodosus proteases AprV2/B2, AprV5/B5 and BprV/B in clinical material from European sheep flocks. Vet Microbiol. (2014) 168:177–84. doi: 10.1016/j.vetmic.2013.11.013

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Kennan RM, Dhungyel OP, Whittington RJ, Egerton JR, Rood JI. The type IV fimbrial subunit gene (fimA) of Dichelobacter nodosus is essential for virulence, protease secretion, and natural competence. J Bacteriol. (2001) 183:4451–8. doi: 10.1128/JB.183.15.4451-4458.2001

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Riffkin MC, Wang LF, Kortt AA, Stewart DJ. A single amino-acid change between the antigenically different extracellular serine proteases V2 and B2 from Dichelobacter nodosus. Gene. (1995) 167:279–83. doi: 10.1016/0378-1119(95)00664-8

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Kennan RM, Wong W, Dhungyel OP, Han X, Wong D, Parker D, et al. The subtilisin-like protease AprV2 is required for virulence and uses a novel disulphide-tethered exosite to bind substrates. PLoS Pathogen. (2010) 6:e1001210. doi: 10.1371/journal.ppat.1001210

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Stäuble A, Steiner A, Frey J, Kuhnert P. Simultaneous detection and discrimination of virulent and benign Dichelobacter nodosus in Sheep of flocks affected by foot rot and in clinically healthy flocks by competitive real-time PCR. J Clin Microbiol. (2014) 52:1228–31. doi: 10.1128/JCM.03485-13

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Frosth S, König U, Nyman A-K, Pringle M, Aspán A. Characterisation of Dichelobacter nodosus and detection of Fusobacterium necrophorum and Treponema spp. in sheep with different clinical manifestations of footrot. Vet Microbiol. (2015) 179:82–90. doi: 10.1016/j.vetmic.2015.02.034

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Witcomb LA, Green LE, Kaler J, Ul-Hassan A, Calvo-Bado LA, Medley GF, et al. A longitudinal study of the role of Dichelobacter nodosus and Fusobacterium necrophorum load in initiation and severity of footrot in sheep. Prevent Vet Med. (2014) 115:48–55. doi: 10.1016/j.prevetmed.2014.03.004

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Witcomb LA, Green LE, Calvo-Bado LA, Russell CL, Smith EM, Grogono-Thomas R, et al. First study of pathogen load and localisation of ovine footrot using fluorescence in situ hybridisation (FISH). Vet Microbiol. (2015) 176:321–7. doi: 10.1016/j.vetmic.2015.01.022

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Best N, Rodoni B, Rawlin G, Beddoe T. The development and deployment of a field-based loop mediated isothermal amplification assay for virulent Dichelobacter nodosus detection on Australian sheep. PLoS ONE. (2018) 13:e0204310. doi: 10.1371/journal.pone.0204310

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Kaneko H, Kawana T, Fukushima E, Suzutani T. Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances. J Biochem Biophys Methods. (2007) 70:499–501. doi: 10.1016/j.jbbm.2006.08.008

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Francois P, Tangomo M, Hibbs J, Bonetti EJ, Boehme CC, Notomi T, et al. Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications. FEMS Immunol Med Microbiol. (2011) 62:41–8. doi: 10.1111/j.1574-695X.2011.00785.x

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Mansour SM, Ali H, Chase CC, Cepica A. Loop-mediated isothermal amplification for diagnosis of 18 World Organization for Animal Health (OIE) notifiable viral diseases of ruminants, swine and poultry. Anim Health Res Rev. (2015) 16:89–106. doi: 10.1017/S1466252315000018

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Sahoo PR, Sethy K, Mohapatra S, Panda D. Loop mediated isothermal amplification: an innovative gene amplification technique for animal diseases. Vet World. (2016) 9:465–9. doi: 10.14202/vetworld.2016.465-469

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Best N, Zanandrez L, Gwozdz J, Klien E, Buller N, Suter R, et al. Assessment of a rtPCR for the detection of virulent and benign Dichelobacter nodosus, the causative agent of ovine footrot, in Australia. BMC Vet Res. (2018) 14:252. doi: 10.1186/s12917-018-1575-0

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Fleiss JL, Levin B, Paik MC. The measurement of interrater agreement. In: Shewart WA, Wilks SS, editors. Statistical Methods for Rates and Proportions. Hoboken, NJ: John Wiley and Sons, Inc. (2004). p. 598–626.

Google Scholar

23. Chomczynski P, Rymaszewski M. Alkaline polyethylene glycol-based method for direct PCR from bacteria, eukaryotic tissue samples, and whole blood. BioTechniques. (2004) 40:454–8. doi: 10.2144/000112149

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Viana GMR, Silva-Flannery L, Lima Barbosa DR, Lucchi N, Do Valle SCN, Farias S, et al. Field evaluation of a real time loop-mediated isothermal amplification assay (RealAmp) for malaria diagnosis in Cruzeiro do Sul, Acre, Brazil. PLoS ONE. (2018) 13:e0200492. doi: 10.1371/journal.pone.0200492

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Thiessen LD, Neill TM, Mahaffee WF. Development of a quantitative loop-mediated isothermal amplification assay for the field detection of Erysiphe necator. PeerJ. (2018) 6:e4639. doi: 10.7717/peerj.4639

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Egerton JR, Parsonson IM. Benign foot rot - a specific interdigital dermatitis of sheep associated wtih infection by less proteolytic strains of Fusiformis nodosus. Austr Vet J. (1969) 45:345–9. doi: 10.1111/j.1751-0813.1969.tb06606.x

CrossRef Full Text | Google Scholar

27. Calvo-Bado LA, Oakley BB, Dowd SE, Green LE, Medley GF, Ul-Hassan A, et al. Ovine pedomics: the first study of the ovine foot 16S rRNA-based microbiome. ISME J. (2011) 5:1426–37. doi: 10.1038/ismej.2011.25

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Graham NPH, Egerton JR. Pathogenesis of Ovine foot-rot: the role of some environmental factors. Austr Vet J. (1968) 44:235–40. doi: 10.1111/j.1751-0813.1968.tb09092.x

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Allworth MB. Challenges in ovine footrot control. Small Rumin Res. (2014) 118:110–3. doi: 10.1016/j.smallrumres.2013.12.007

CrossRef Full Text | Google Scholar

30. Greber D, Bearth G, Luchinger R, Schuepbach-Regula G, Steiner A. Elimination of virulent strains (aprV2) of Dichelobacter nodosus from feet of 28 Swiss sheep flocks: a proof of concept study. Vet J. (2016) 216:25–32. doi: 10.1016/j.tvjl.2016.06.015

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Nixon GJ, Svenstrup HF, Donald CE, Carder C, Stephenson JM, Morris-Jones S, et al. A novel approach for evaluating the performance of real time quantitative loop-mediated isothermal amplification-based methods. Biomol Detect Quant. (2014) 2:4–10. doi: 10.1016/j.bdq.2014.11.001

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Locher I, Giger L, Frosth S, Kuhnert P, Steiner A. Potential transmission routes of Dichelobacter nodosus. Vet Microbiol. (2018) 218:20–4. doi: 10.1016/j.vetmic.2018.03.024

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: LAMP, in-field, footrot, ovine, aprV2, on-farm diagnostic

Citation: Best N, Rawlin G, Suter R, Rodoni B and Beddoe T (2019) Optimization of a Loop Mediated Isothermal Amplification (LAMP) Assay for In-Field Detection of Dichelobacter nodosus With aprV2 (VDN LAMP) in Victorian Sheep Flocks. Front. Vet. Sci. 6:67. doi: 10.3389/fvets.2019.00067

Received: 27 November 2018; Accepted: 15 February 2019;
Published: 08 March 2019.

Edited by:

Subhash Verma, Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, India

Reviewed by:

Aneesh Thakur, University of Copenhagen, Denmark
Santhamani Ramasamy, Albert Einstein College of Medicine, United States

Copyright © 2019 Best, Rawlin, Suter, Rodoni and Beddoe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Travis Beddoe, t.beddoe@latrobe.edu.au

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.